Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs
SGLT2抑制剂和GLP-1受体激动剂的使用率及其在动脉粥样硬化性心血管疾病和2型糖尿病患者中的医疗机构差异:来自美国退伍军人事务部的见解
期刊:
影响因子:
doi:10.2337/dc21-1815
Mahtta, Dhruv; Ramsey, David J; Lee, Michelle T; Chen, Liang; Al Rifai, Mahmoud; Akeroyd, Julia M; Vaughan, Elizabeth M; Matheny, Michael E; Santo, Karla Rodrigues do Espirito; Navaneethan, Sankar D; Lavie, Carl J; Birnbaum, Yochai; Ballantyne, Christie M; Petersen, Laura A; Virani, Salim S
SGLT2
GLP-1
信号转导
心血管疾病
心血管
代谢
糖尿病
动脉粥样硬化